Thymoquinone induces G2/M cell cycle phase arrest and apoptosis through inhibition of JNK phosphorylation and induction of p53 and p21 expression in HT-1080 fibrosarcoma cells
Abstract:Background
Resistance to chemotherapy is a major cause of failure in cancer treatment. Several approaches have been used to circumvent this resistance, including the co-treatment with ABC proteins inhibitors. However, such strategy did not significantly improve cancer therapy due to toxicity and bioavailability of these compounds. Antitumor activity of natural compounds has been largely explored during the last decades as an alternative to improve cancer treatment. One of explored natural molecules is thymoqu… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.